Effects of oestrogen on vulvovaginal candidosis
- PMID: 34699636
- DOI: 10.1111/myc.13385
Effects of oestrogen on vulvovaginal candidosis
Abstract
As a frequently occurring infectious disease mainly caused by Candida albicans, vulvovaginal candidosis (VVC) affects more than 100 million women worldwide every year. Multiple factors that influence C. albicans colonisation have been linked to the incidence of VVC, including high levels of circulating oestrogen due to pregnancy, the use of oral contraceptives, and hormone replacement therapy. This review provides an overview of the current understanding of the mechanism(s) by which oestrogen contributes to VVC, which might provide meaningful guidance to the prevention and treatment of this disease.
Keywords: Candida albicans; neutrophils; oestrogen; virulence; vulvovaginal candidosis.
© 2021 Wiley-VCH GmbH.
References
REFERENCES
-
- Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369:1961-1971. doi:10.1016/s0140-6736(07)60917-9
-
- Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010;23:253-273. doi:10.1128/CMR.00076-09
-
- Sobel JD. Candidal vulvovaginitis. Clin Obstet Gynecol. 1993;36:153-165. doi:10.1097/00003081-199303000-00021
-
- Hong E, Dixit S, Fidel PL, Bradford J, Fischer G. Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition. J Low Genit Tract Dis. 2014;18:31-38. doi:10.1097/LGT.0b013e318287aced
-
- Goncalves B, Azevedo NM, Henriques M, Silva S. Hormones modulate Candida vaginal isolates biofilm formation and decrease their susceptibility to azoles and hydrogen peroxide. Med Mycol. 2020;58:341-350. doi:10.1093/mmy/myz070
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
